Advertisement

Medicinal Chemistry Research

, Volume 27, Issue 2, pp 653–668 | Cite as

Newer series of trioxane derivatives as potent antimalarial agents

  • Mithun Rudrapal
  • Zartaj Washmin Banu
  • Dipak Chetia
Original Research
  • 196 Downloads

Abstract

Among synthesized 1,2,4-trioxane derivatives, six compounds were found to be considerably potent, with better activity against resistant strain of P. falciparum than the sensitive strain. The IC50 values of the best compound with 4-hydroxyphenyl substitution were found to be 0.391 and 0.837 µg/mL against sensitive and resistant strain of P. falciparum, respectively. Results of the tested compounds were comparable with that of the standard drug, chloroquine (IC50 = 0.044 and 0.205 µg/mL against sensitive and resistant strain of P. falciparum, respectively). Docking simulation, in silico drug-likeness and ADMET studies further validated the results of in vitro antimalarial activity. Trioxane derivatives exhibited good binding affinity for the P. falciparum cysteine protease falcipain 2 receptor (PDB id: 3BPF) with well defined drug-like and pharmacokinetic properties based on Lipinski’s rule of five with additional physicochemical and ADMET parameters. In view of having antimalarial potential, newly reported 1,2,4-trioxane derivative(s) may be useful as novel antimalarial lead(s) in the discovery and development of future antimalarial drug candidates as P. falciparum falcipain 2 inhibitors against resistant malaria.

Keywords

P. falciparum Resistance 1,2,4-Trioxane Falcipain 2 inhibitors Antimalarial 

Notes

Acknowledgements

Authors are thankful to Bioinformatics Infrastructure Facility, Center for Biotechnology and Bioinformatics, Dibrugarh University, Dibrugarh, Assam (India) for carrying out in silico studies. Authors are also thankful to SAIF, Panjab University, Chandigarh for providing spectral data of synthesized compounds.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

References

  1. Alam S, Khan F (2014) QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNAtopoisomerase IIα. Drug Des Dev Ther 8:183–195Google Scholar
  2. Balint GA (2001) Artemisinin and its derivatives: an important new class of antimalarial agents. Pharmacol Ther 90:261–265CrossRefPubMedGoogle Scholar
  3. Carreno MC, Gonzalez-Lopez M, Urbano A (2006) Oxidative de-aromatization of para-alkyl phenols into para-peroxyquinols and para-Quinols mediated by oxone as a source of singlet oxygen. Angew Chem Int Ed 45:2737–2741CrossRefGoogle Scholar
  4. Cumming JN, Ploypradith P, Posner GH (1996) Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action. Adv Pharmacol 37:253–297CrossRefGoogle Scholar
  5. Debnath B, Ganguly S (2016) Synthesis, biological evaluation, in silico docking, and virtual ADME studies of 2-[2-oxo-3-(arylimino)indolin-1-yl]-N-arylacetamides as potent anti-breast cancer agents. Monatsh Chem 147:565–574CrossRefGoogle Scholar
  6. Faidallah HM, Al-Mohammadi MM, Alamry KA, Khan KA (2016) Synthesis and biological evaluation of fluoropyrazolesulfonylurea and thiourea derivatives as possible antidiabetic agents. J Enzyme Inhib Med Chem 31(sup1):157–163CrossRefPubMedGoogle Scholar
  7. Garner P, Graves PM (2005) The benefits of artemisinin combination therapy for malaria extend beyond the individual patient. PLoS Med 2(4):e105CrossRefPubMedPubMedCentralGoogle Scholar
  8. Geleta G, Ketema T (2016) Severe malaria associated with P. falciparum and P. vivax among children in Pawe Hospital, Northwest Ethiopia. Malar Res Treat 6:1–7Google Scholar
  9. Gogoi J, Chetia D, Kumawat MK, Rudrapal M (2016) Synthesis and antimalarial activity evaluation of some mannich bases of tetraoxane-phenol conjugate. Indian J Pharm Edu Res 50(4):591–597CrossRefGoogle Scholar
  10. Grover J, Kumar V, Singh V, Khemraj B, Sobhia ME, Jachak SM (2014) Synthesis, biological evaluation, molecular docking and theoretical evaluation of ADMET properties of nepodin and chrysophanol derivatives as potential cyclooxygenase (COX-1, COX-2) inhibitors. Eur J Med Chem 80:47–56CrossRefPubMedGoogle Scholar
  11. Kashid AM, Dube PN, Alkutkar PG, Bothara KG, Mokale SN, Dhawale SS (2013) Synthesis, biological screening and ADME prediction of benzylindole derivatives as novel anti-HIV-1, anti-fungal and anti-bacterial agents. Med Chem Res 22:4633–4640CrossRefGoogle Scholar
  12. Kashyap A, Chetia D, Rudrapal M (2016) Synthesis, antimalarial activity evaluation and drug-likeness study of some new Quinoline-Lawsone Hybrids. Indian J Pharm Sci 78(6):892–911CrossRefGoogle Scholar
  13. Kerns EH, Di L (2008) Drug-like properties: concepts, structure design and methods from ADME to toxicity optimization. Academic Press, New York, p 6–14CrossRefGoogle Scholar
  14. Khoshneviszadeh M, Shahraki O, Khoshneviszadeh M, Foroumadi A, Firuzi O, Edraki N, Nadri H, Moradi A, Shafiee A, Miri R (2016) Structure-based design, synthesis, molecular docking study and biological evaluation of 1,2,4-triazine derivatives acting as COX/15-LOX inhibitors with anti-oxidant activities. Enzyme Inhib Med Chem 31(6):1602–1611CrossRefGoogle Scholar
  15. Kitchen DB, Decornez H, Furr JR, Bajorath J (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev 3:936–849Google Scholar
  16. Kyle DE, Teja-Isavadharm P, Li Q, Leo K (1998) Pharmacokinetics and pharmacodynamics of qinghaosu derivatives: how do they impact on the choice of drug and the dosage regimens? Med Trop 58:38–44Google Scholar
  17. Lambros C, Vanderberg JP (1976) Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65:418–420CrossRefGoogle Scholar
  18. Lionta E, Spyrou G, Vassilatis DK, Cournia Z (2004) Structure-based virtual screening for drug discovery: principles, applications and recent advances. Curr Top Med Chem 14:1923–1938CrossRefGoogle Scholar
  19. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3–26CrossRefGoogle Scholar
  20. Liu Y, Cui K, Lu W, Luo W, Wang J, Huang J, Guo C (2011) Synthesis and antimalarial activity of novel dihydro-artemisinin derivatives. Molecule 16:4527–4538CrossRefGoogle Scholar
  21. Meshnick SR (2002) Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol 32:1655–1660CrossRefPubMedGoogle Scholar
  22. Nikam MD, Mahajan PS, Damale MG et al. (2015) Synthesis, molecular docking and biological evaluation of some novel tetrazolo[1,5-a]quinoline incorporated pyrazoline and isooxazoline derivatives. Med Chem Res 24:3372–3386CrossRefGoogle Scholar
  23. Oliveria R, Newton AS, Guedes RC, Miranda D, Amewa RK, Srivastava A, Gut J, Rosenthal PJ, O’Neill PM, Ward S, Lopes F, Moreira R (2013) An endoperoxide-based hybrid approach to deliver Falcipain inhibitors inside malaria parasites. Chem Med Chem 8:1528–1536CrossRefGoogle Scholar
  24. Pandey S, Agarwal P, Srivastava K, RajaKumar S, Puri SK, Verma P, Saxena JK, Sharma A, Lal J, Chauhan PMS (2013) Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivatives as potent antimalarial agents. Eur J Med Chem 66:69–81CrossRefPubMedGoogle Scholar
  25. Park VK, O’Neill PM, Maggs JL (1998) Safety assessment of peroxide antimalarials: clinical and chemical perspectives. Br J Clin Pharmacol 46:521–529CrossRefPubMedPubMedCentralGoogle Scholar
  26. Paul M, O’Neill PM, Posner GH (2004) A medicinal chemistry perspective on Artemisinin and related endoperoxides. J Med Chem 47(12):2945–2964CrossRefGoogle Scholar
  27. Roy S, Chetia D, Rudrapal M, Prakash A (2013) Synthesis and antimalarial activity study of some new Mannich bases of 7-chloro-4-aminoquinoline. Med Chem 9:379–383CrossRefPubMedGoogle Scholar
  28. Rubush DM, Morges MA, Rose BJ, Thamm DH, Rovis T (2012) An asymmetric synthesis of 1,2,4-trioxane anticancer agents via desymmetrization of Peroxyquinols through a Brønsted acid catalysis cascade. J Am Chem Soc 134:13554–13557CrossRefPubMedPubMedCentralGoogle Scholar
  29. Rudrapal M, Chetia D (2016) Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold. Drug Des Dev Ther 10:3575–3590CrossRefGoogle Scholar
  30. Rudrapal M, Chetia D, Prakash A (2013) Synthesis, antimalarial- and antibacterial activity evaluation of some new 4-aminoquinoline derivatives. Med Chem Res 22:3703–3711CrossRefGoogle Scholar
  31. Sapre NS, Gupta S, Pancholi N, Sapre N (2008) Molecular docking studies on tetrahydroimidazo-[4,5,1-jk] [1,4]-benzodiazepinone (TIBO) derivatives as HIV-1 NNRT inhibitors. J Comput Aided Mol Des 22:69–80CrossRefPubMedGoogle Scholar
  32. Sashidhara KV, Avula SR, Palnati GR, Singh SV, Srivastava K, Puri SK, Saxena JK (2012a) Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum. Bioorg Med Chem 22:5455–5459CrossRefGoogle Scholar
  33. Sashidhara KV, Kumar K, Dodda RP, Krishna NN, Agarwal P, Srivastava K, Puri SK (2012b) Coumarin–trioxane hybrids: Synthesis and evaluation as a new class of antimalarial scaffolds. Bioorg Med Chem 22:3926–3930CrossRefGoogle Scholar
  34. Sharma D, Chetia D, Rudrapal M (2016) Design, synthesis and antimalarial activity of some new 2-hydroxy-1,4-naphthoquinone-4-hydroxyaniline Hybrid Mannich Bases. Asian J Chem 28(4):782–788CrossRefGoogle Scholar
  35. Shukla S, Srivastava RS, Shrivastava SK, Sodhi A, Kumar P (2013) Synthesis, cytotoxic evaluation, docking and in silico pharmacokinetic prediction of 4-arylideneamino/cycloalkylidineamino 1, 2- naphthoquinone thiosemicarbazones. J Enzyme Inhib Med Chem 28(6):1192–1198CrossRefPubMedGoogle Scholar
  36. Silverstein RM, Webster FX (2005) Spectrometric identification of organic compounds. Wiley Inc, New York, p 205–213Google Scholar
  37. Singh J, Kumar M, Mansuri R, Sahoo GS, Deep A (2016) Inhibitor designing, virtual screening, and docking studies for methyltransferase: A potential target against dengue virus. J Pharm Bioallied Sci 8(3):188–194CrossRefPubMedPubMedCentralGoogle Scholar
  38. Singh S, Srivastava P (2015) Molecular docking studies of myricetin and its analogs against human PDK-1 kinase as candidate drugs for cancer. Comput Mol Biosci 5:20–33CrossRefGoogle Scholar
  39. Singh SP, Konwar BK (2012) Molecular docking studies of quercetin and its analogs against human inducible nitric oxide synthase. SpringerPlus 1:69CrossRefPubMedPubMedCentralGoogle Scholar
  40. Tang Y, Dong Y, Vennerstrom JL (2004) Synthetic peroxides as antimalarials. Med Res Rev 24:425–448CrossRefPubMedGoogle Scholar
  41. Trager W, Jensen JB (1976) Human malaria parasites in continuous culture. Science 193:673–675CrossRefPubMedGoogle Scholar
  42. Usha T, Middha SK, Goyal AK, Karthik M, Manoj DA, Faizan S, Goyal P, Prashanth HP, Pande V (2014) Molecular docking studies of anti-cancerous candidates in Hippophae rhamnoides and Hippophae salicifolia. J Biomed Res 28(5):406–415PubMedPubMedCentralGoogle Scholar
  43. White NJ (1994) Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives. Trans R Soc Trop Med Hyg 88:S41–S43CrossRefPubMedGoogle Scholar
  44. White NJ (1997) Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 41:1413–1422PubMedPubMedCentralGoogle Scholar
  45. World Malaria Report (2016) World Health Organization, GenevaGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Mithun Rudrapal
    • 1
  • Zartaj Washmin Banu
    • 1
  • Dipak Chetia
    • 1
  1. 1.Department of Pharmaceutical SciencesDibrugarh UniversityDibrugarhIndia

Personalised recommendations